Urinary metabolic profile and stone composition in kidney stone formers with and without heart disease
| Autor: | William G. Robertson, Gianmarco Lombardi, Robert J Unwin, Giovanni Gambaro, Shabbir Moochhala, Matteo Bargagli, Pietro Manuel Ferraro |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Nephrology
medicine.medical_specialty Heart Diseases Heart disease Urinary system Urine Gastroenterology Citric Acid Kidney Calculi Internal medicine Diabetes mellitus Diabetes Mellitus medicine Humans Magnesium Citrates Myocardial infarction business.industry medicine.disease Kidney stone disease Hypertension Metabolome Calcium Kidney stones business |
| Zdroj: | Journal of Nephrology. 35:851-857 |
| ISSN: | 1724-6059 |
| Popis: | Objective Kidney stone disease seems to be associated with an increased risk of incident cardiovascular outcomes; the aim of this study is to identify differences in 24-h urine excretory profiles and stone composition among stone formers with and without cardiovascular disease (CVD). Methods Data from patients attending the Department of Renal Medicine’s metabolic stone clinic from 1995 to 2012 were reviewed. The sample was divided according to the presence or absence of CVD (myocardial infarction, angina, coronary revascularization, or surgery for calcified heart valves). Univariable and multivariable regression models, adjusted for age, sex, BMI, hypertension, diabetes, eGFR, plasma bicarbonate and potential renal acid load of foods were used to investigate differences across groups. Results 1826 patients had available data for 24-h urine analysis. Among these, 108 (5.9%) had a history of CVD. Those with CVD were older, have higher prevalence of hypertension and diabetes and lower eGFR. Univariable analysis showed that patients with CVD had significantly lower 24-h urinary excretions for citrate (2.4 vs 2.6 mmol/24 h, p = 0.04), magnesium (3.9 vs 4.2 mmol/24 h, p = 0.03) and urinary pH (6.1 vs 6.2, p = 0.02). After adjustment for confounders, differences in urinary citrate and magnesium excretions remained significant. No differences in the probability of stone formation or stone compositions were found. Conclusions Stone formers with CVD have lower renal alkali excretion, possibly suggesting higher acid retention in stone formers with cardiovascular comorbidities. Randomized clinical trials including medications and a controlled diet design are needed to confirm the results presented here. Graphic abstract |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink